Joseph [Analyst]'s questions to Conmed Corp (CNMD) leadership • Q4 2024
Question
Joseph from Needham & Company asked about new CEO Patrick Beyer's strategic directives, the scope of the planned portfolio 'deep dive,' the status of the COO search, and the latest clinical data profile for the BioBrace platform.
Answer
CEO Patrick Beyer stated he will not hire a COO and will retain direct oversight of commercial operations. His six focus areas are AirSeal, Orthopedic operations, debt reduction, BioBrace, Buffalo Filter, and Foot & Ankle. The portfolio review will aim to enhance long-term growth and profitability. He added that BioBrace is used in nearly 50 procedures, supported by 14 publications and 9 ongoing studies, with a major trial readout expected in late 2026.